中国医疗器械高峰论坛,DEVICE CHINA , www.devicechina.com.cn
由苏州生物纳米园(BioBAY)主办的第二届中国医疗器械高峰论坛将于2012年9月17日至18日在中国苏州隆重举行。2011年9月,超过200名来自中国、美国及欧洲的优秀投资者、企业家、行业高层和政府官员参加了第一届高峰论坛，确立了其成为专注服务于中国医疗器械行业高端领导者的、中国最首要的行业 会议。
第二届中国医疗器械高端峰会将秉承其创办宗旨，为来自中国和全球各地区最优秀的医疗器械行业领袖及专家学者构建高效的沟通合作平台,探讨医疗器械行业最前沿动态,促进潜在的商务合作。
DEVICE CHINA 2012 会议特色
结合相关政府政策法规，对中国医疗器械行业进行全面准确的总结及展望
汲取中国最成功的医疗器械企业的战略经验，聆听中外知名企业高层就热点问题的激烈讨论
深度探讨中国医疗器械行业的贸易形势 ，借鉴企业国际收购的实战经验
中国高端医疗器械技术创新、产品研发、临床研究及政策法规现状与展望
来自中国最具创新实力的十家医疗器械企业及关注中国市场的五家欧美知名企业的精彩公司路演
哪些行业专家将出席DEVICE CHINA?
参会者层次: 中国医疗行业最知名的上市及私有公司的企业家和高层管理者，领先的生物技术公司及医疗服务企业的领导者,行业相关政府官员，知名行业投资机构及服务商
行业: 医疗器械,健康医疗服务,政府机构以及全球知名投资机构
中国医疗器械高峰论坛,DEVICE CHINA ,  苏州生物纳米科技园 BioBay

联系方式:
Eric Lu
Lychee Group, LLC
电话: 86-21-31263933转8001
移动电话: +86-13585594822
传真: 86-21-6208 2226
地址: 上海市卢湾区进贤路169号2楼C座
电子邮件: eric.lu@lycheegroup.com

Over 200 of the most influential medical device inventors, entrepreneurs, executives, investors and government officials are expected to attend this year’s event. The successful inaugural Device China event in September 2011 established the meeting as the only high-quality event dedicated for high-end professionals interested in China’s medical device industry.
Device China 2012 provides a powerful communication and partnering platform for Chinese and global medical device thought leaders and professionals to discuss the latest industry developments and form new partnerships.
 
An annual report of the China medical device industry along with analysis of Chinese government policy for medical devices?
Hear from the most successful Chinese medical device companies and their discussions with multinational executives
In-depth look at the medical device transactions landscape in China, including case studies providing multinational perspectives on acquisitions
Updates on medical device inventions, innovations, clinical trials and regulatory affairs?
A special showcase of top 10 Chinese innovative device companies and top 5 selected US/EU device companies interested in China

Level of Attendees: Entrepreneurs and executives from the most promising public and private Chinese medical device companies, executives from leading life sciences and healthcare services companies, relevant key government officials, premier public and private investors and service providers
Industries: Medical devices, healthcare services, government, and global healthcare investors